Valuation : Evotec SE

Market Cap 582M 676M 546M 500M 933M 63.94B 940M 6.46B 2.52B 32.67B 2.54B 2.48B 105B P/E 2026 *
-2.79x
P/E 2027 * -7.61x
Enterprise Value 725M 842M 680M 622M 1.16B 79.63B 1.17B 8.05B 3.13B 40.7B 3.16B 3.09B 131B EV / Sales 2026 *
1.21x
EV / Sales 2027 * 1.03x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day-2.08%
1 week-3.88%
Current month-0.86%
1 month-6.62%
3 months-37.09%
6 months-43.06%
Current year-40.95%
1 week 3.12
Extreme 3.118
3.37
1 month 3.12
Extreme 3.118
3.88
Current year 3.12
Extreme 3.118
6.73
1 year 3.12
Extreme 3.118
7.3
3 years 3.12
Extreme 3.118
23.44
5 years 3.12
Extreme 3.118
45.83
10 years 3.12
Extreme 3.118
45.83
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO - 01/05/2026
Chief Operating Officer - 01/05/2026
Director TitleAgeSince
Director/Board Member 58 19/06/2019
Director/Board Member 64 01/06/2021
Director/Board Member 59 10/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
20/5/26 Exercice

Chief Technology Officer

12,462 0.0070%
4/5/26 Buy 15,510 0.0087%
4/5/26 Buy

Head of Human Resources

15,228 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
-2.11%-3.88%-43.56%-85.27% 676M
-2.22%-2.74%-1.80%+14.64% 50.35B
-1.17%-0.03%+433.53%+516.83% 45.2B
-2.05%+1.66%+44.56%+20.47% 44.71B
-1.08%-2.29%+12.42%+74.93% 41.24B
+0.43%-2.20%+14.55%+49.08% 33.08B
-1.79%+7.24% - - 17.81B
-0.06%-1.31%+22.90%+123.61% 16.56B
-0.52%+1.00%+16.41%+28.62% 14.82B
-1.49%-0.75%+78.24%+41.61% 14B
Average -1.20%-0.46%+64.14%+87.17% 27.84B
Weighted average by Cap. -1.26%-0.65%+92.77%+125.55%

Financials

2026 *2027 *
Net sales 601M 698M 564M 516M 963M 66.02B 971M 6.67B 2.6B 33.74B 2.62B 2.57B 109B 724M 842M 680M 622M 1.16B 79.56B 1.17B 8.04B 3.13B 40.66B 3.16B 3.09B 131B
Net income -202M -235M -190M -173M -324M -22.19B -326M -2.24B -873M -11.34B -882M -862M -36.53B -48.25M -56.08M -45.28M -41.43M -77.32M -5.3B -77.93M -536M -209M -2.71B -211M -206M -8.73B
Net Debt 143M 166M 134M 123M 229M 15.69B 231M 1.59B 618M 8.02B 623M 610M 25.83B 162M 188M 152M 139M 260M 17.82B 262M 1.8B 701M 9.11B 708M 692M 29.32B
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,461
Date Price Change Volume
05/09/26 EUR 3.216 -1.77% 669,301
03/09/26 EUR 3.274 -0.97% 485,055
02/09/26 EUR 3.306 +4.95% 906,734
01/09/26 EUR 3.150 -2.96% 823,198
31/08/26 EUR 3.246 -3.05% 1,071,165
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.274EUR
Average target price
4.586EUR
Spread / Average Target
+40.06%

Quarterly revenue - Rate of surprise